Canadian Bishops Issue Clarification on Notice Regarding AstraZeneca, Johnson & Johnson Vaccines

Canadian Bishops Issue Clarification on Notice Regarding AstraZeneca, Johnson & Johnson Vaccines
A vial of some of the first 500,000 of the two million AstraZeneca COVID-19 vaccine doses that Canada has secured through a deal with the Serum Institute of India in partnership with Verity Pharma at a facility in Milton, Ont., Canada, on March 3, 2021. Carlos Osorio - POOL/The Canadian Press
|Updated:

The Canadian Conference of Catholic Bishops (CCCB) clarified on March 11 regarding an earlier notice they sent to Catholics, recommending the choice of alternatives over the AstraZeneca and Johnson & Johnson COVID-19 vaccines due to their use of “abortion-derived cell lines in their development, production, and confirmatory testing.”

“This Note was published in response to questions from Catholics who were concerned about the moral permissibility of receiving currently-approved COVID-19 vaccines,” wrote the national assembly of the bishops, in their clarification of a notice (pdf) they sent on Tuesday. “The Note did not refer to, nor intend to question the medical efficacy of any vaccine.”